Analysis of the sodium pump subunit ATP1A3 in glioma patients: Potential value in prognostic prediction and immunotherapy

In conclusion, we showed that ATP1A3 is a highly promising treatment target in GBM and the risk score is an independent prognostic factor for cancer and can be used to help guide the prediction of survival time in patients with GBM.PMID:38615384 | DOI:10.1016/j.intimp.2024.112045
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Source Type: research